Fibroblast growth factor receptor-1 associated myeloproliferative neoplasm and T-lymphoblastic lymphoma
Myeloid and lymphoid hematological malignancies with eosinophilia and abnormalities of fibroblast growth factor receptor-1 (FGFR1) result from the formation of abnormal fusion genes that encode constitutively activated tyrosine kinases. The WHO classification (2008) of hematolymphoid neoplasms recog...
Saved in:
Main Authors: | Gayathri Gopan (Author), T M Anoop (Author), N P Prakash (Author), Rakul Nambiar (Author), R Krishnachandran (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted therapies for myeloproliferative neoplasms
by: Bing Li, et al.
Published: (2019) -
The Hematopoietic Niche in Myeloproliferative Neoplasms
by: Annette H. Schmitt-Graeff, et al.
Published: (2015) -
Disruption of asxl1 results in myeloproliferative neoplasms in zebrafish
by: Evisa Gjini, et al.
Published: (2019) -
Myeloproliferative Neoplasms: Fatigue, depression & hemoglobi
by: Marina Stal
Published: (2019) -
SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms
by: Amandeep Aujla, et al.
Published: (2018)